RefSeq: expanding the Prokaryotic Genome Annotation Pipeline reach with protein family model curation
its once-weekly injection schedule greatly improves convenience and adherence compared to the more frequent dosing requirements of insulin
Consistently, the mRNA and protein levels of hepatic CYP8B1 were elevated, while the percentage of 12-OH BAs was increased and the proportion of non-12-OH BAs was reduced in the gallbladder bile, ileum, liver, serum, and urine in MMI mice compared to untreated control mice (CT mice) (Supplementary Fig
Early results from ongoing clinical studies are indicating the GLP-1 medications may successfully treat numerous other conditions including non-alcoholic fatty liver disease (known as metabolic dysfunction-associated steatohepatitis or MASH), sleep apnea, heart failure, diabetic kidney disease and Alzheimers disease
If IGF-1 exceeds the upper normal limit, tesamorelin dose reduction or discontinuation should be considered immediately